Document Detail


Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
MedLine Citation:
PMID:  604477     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cellular immune reactivity was examined in control subjects and in 16 patients with rheumatoid arthritis before and after administration of levamisole. Prior to levamisole treatment, this population of patients with rheumatoid arthritis had diminished cellular immunity as measured by skin test reactivity, lymphocyte stimulation by antigen and by PHA, lymphocyte count and percentage and absolute numbers of long-incubation rosette-forming cells (RFC). Administration of levamisole caused enhancement of skin test reactivity and flares at dinitrochlorobenzene (DNCB) test sites which were not paralleled by an increase in lymphocyte stimulation by the same antigens in vitro or enhancement in the PHA response. The increase in lymphocyte count and RFC was borderline (p = .06). Of the 16 patients who received levamisole for three months, nine patients showed at least one physical sign of improvement, five patients remained unchanged, and two patients experienced progression of their disease.
Authors:
C M Basch; L E Spitler; E G Engleman; E P Engleman
Related Documents :
2091987 - Effect of chemotherapy on cell counts in peripheral blood & bronchoalveolar lavage of p...
3074627 - The effect of thymic substances on t circulating cells of patients treated for hodgkin'...
8416667 - Evaluation of immunocompetence and nutritional status in patients with bulimia nervosa.
9050957 - Immunological monitoring of azathioprine treatment in multiple sclerosis patients.
1052307 - Postural dependence of reaction time in normal subjects and patients with focal brain l...
10336597 - Association between mast cell chymase genotype and atopic eczema: comparison between pa...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  4     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1977  
Date Detail:
Created Date:  1978-04-17     Completed Date:  1978-04-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  377-88     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Arthritis, Rheumatoid / drug therapy,  immunology*
Blood Sedimentation
Female
Humans
Immunity, Cellular / drug effects*
Immunotherapy
Leukocyte Count
Levamisole / pharmacology*,  therapeutic use
Lymphocytes / immunology
Male
Middle Aged
Rosette Formation
Skin Tests
Chemical
Reg. No./Substance:
14769-73-4/Levamisole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of adjuvant arthritis in the rat by an oxonate diet: sequential studies.
Next Document:  Serum ferritin levels in anemia of rheumatoid arthritis.